SPDR S&P Pharmaceuticals ETF Sees Surging Volume Amid Mixed Stock Performance
Unprecedented Trading Activity
The SPDR S&P Pharmaceuticals ETF (XPH) experienced a remarkable surge in trading volume on Tuesday afternoon. Over 210,000 shares have changed hands, significantly higher than the three-month average of approximately 38,000 shares. Despite this activity, shares of XPH dipped by about 0.2% for the day.
Key Players Show Varied Performance
On the trading floor, Pfizer stood out with over 11.2 million shares traded, remaining relatively flat for the session. In contrast, Organon saw a decrease of around 5.1%, with over 4.0 million shares exchanged. On a positive note, Pacira Biosciences emerged as the top performer within the ETF, gaining about 3.6% on the day. Meanwhile, Neumora Therapeutics struggled, experiencing a decline of roughly 7%.
VIDEO: Tuesday’s ETF with Unusual Volume: XPH
The views and opinions expressed herein are solely those of the author and do not necessarily reflect those of Nasdaq, Inc.
